Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 29-05-2014 | Practice Area: | Equity Capital Markets |
| Deal Title: | CSPC Pharmaceutical Group Share Placement | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk advised UBS AG, Hong Kong Branch, Goldman Sachs (Asia) L.L.C and Morgan Stanley and Co. International plc in their capacity as placing agents for the placement of 600,000,000 shares in CSPC Pharmaceutical Group Limited (CSPC) for a total consideration of approximately HKD3.733 billion.
CSPC is incorporated in Hong Kong with its shares listed on The Stock Exchange of Hong Kong Limited. It is primarily engaged in the manufacture and sale of pharmaceutical products.
The Davis Polk team included partners Paul Chow and James C. Lin and associates Peter Cheng, Shih-Jern Liang and Wilson Chan. All members of the Davis Polk team are based in the Hong Kong office.
|
||
| Financial Center: | Hong Kong | Value: | 100.01-500.00 |
| Advised Party: | Lead Manager | Law Firm | Davis Polk |
| Issuer Jurisdiction - | Hong Kong | Listing Jurisdiction - | Hong Kong |
| Classification: |
Secondary Offerings and Placings Hong Kong Stock Exchange: |
Lawyer | Paul Chow |
